Smith, Salley & Associates Eli Lilly & CO Transaction History

Smith, Salley & Associates

$1.48 Billion
Q3 2024

A detailed history of Smith, Salley & Associates transactions in Eli Lilly & CO stock. As of the latest transaction made, Smith, Salley & Associates holds 1,631 shares of LLY stock, worth $1.25 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

1,631

Previous 1,559 4.62%

Holding current value

$1.25 Million

Previous $1.41 Million 2.34%

% of portfolio

0.1%

Previous 0.1%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$772.14 - $960.02 $55,594 - $69,121	72 Added 4.62%	1,631 $1.44 Million
Q2 2024 Jul 29, 2024	BUY	$724.87 - $909.04 $193,540 - $242,713	267 Added 20.67%	1,559 $1.41 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $1.12 Million - $1.5 Million	-1,887 Reduced 59.36%	1,292 $1.01 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $13,654 - $16,097	26 Added 0.82%	3,179 $1.85 Million
Q3 2023 Oct 27, 2023	SELL	$434.7 - $599.3 $37,818 - $52,139	-87 Reduced 2.69%	3,153 $1.69 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $265,510 - $355,017	-757 Reduced 18.94%	3,240 $1.52 Million
Q1 2023 May 03, 2023	SELL	$310.63 - $364.82 $23,918 - $28,091	-77 Reduced 1.89%	3,997 $1.37 Million
Q4 2022 Feb 03, 2023	BUY	$321.55 - $374.67 $321 - $374	1 Added 0.02%	4,074 $1.49 Million
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $9,190 - $10,473	31 Added 0.77%	4,073 $1.32 Million
Q2 2022 Aug 01, 2022	SELL	$278.73 - $327.27 $28,430 - $33,381	-102 Reduced 2.46%	4,042 $1.31 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $91,998 - $114,330	-392 Reduced 8.64%	4,144 $1.19 Million
Q4 2021 Feb 10, 2022	SELL	$224.85 - $279.04 $51,040 - $63,342	-227 Reduced 4.77%	4,536 $1.25 Million
Q3 2021 Nov 05, 2021	SELL	$221.6 - $272.71 $18,836 - $23,180	-85 Reduced 1.75%	4,763 $1.1 Million
Q2 2021 Aug 09, 2021	SELL	$180.55 - $233.54 $17,332 - $22,419	-96 Reduced 1.94%	4,848 $1.11 Million
Q1 2021 Apr 30, 2021	BUY	$164.32 - $212.72 $133,263 - $172,515	811 Added 19.62%	4,944 $924,000
Q4 2020 Jan 28, 2021	SELL	$130.46 - $172.63 $4,827 - $6,387	-37 Reduced 0.89%	4,133 $698,000
Q3 2020 Nov 05, 2020	SELL	$146.22 - $169.13 $7,164 - $8,287	-49 Reduced 1.16%	4,170 $617,000
Q2 2020 Aug 04, 2020	SELL	$136.42 - $164.18 $24,964 - $30,044	-183 Reduced 4.16%	4,219 $693,000
Q1 2020 Apr 24, 2020	BUY	$119.05 - $147.35 $24,286 - $30,059	204 Added 4.86%	4,402 $611,000
Q4 2019 Jan 27, 2020	BUY	$106.92 - $132.43 $23,522 - $29,134	220 Added 5.53%	4,198 $551,000
Q3 2019 Oct 30, 2019	SELL	$106.79 - $116.16 $39,619 - $43,095	-371 Reduced 8.53%	3,978 $445,000
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $4,341 - $5,109	-39 Reduced 0.89%	4,349 $564,000
Q3 2018 Nov 06, 2018	SELL	$85.86 - $107.31 $90,496 - $113,104	-1,054 Reduced 19.37%	4,388 $471,000
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $1,438 - $1,650	19 Added 0.35%	5,442 $465,000
Q1 2018 May 09, 2018	SELL	$74.21 - $87.6 $49,052 - $57,903	-661 Reduced 10.86%	5,423 $420,000
Q4 2017 Feb 12, 2018	SELL	$81.94 - $87.89 $43,428 - $46,581	-530 Reduced 8.01%	6,084 $513,000
Q3 2017 Nov 02, 2017	BUY	$77.07 - $85.54 $509,740 - $565,761	6,614	6,614 $566,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.

Account

Smith, Salley & Associates Eli Lilly & CO Transaction History